TY  - GEN
AU  - Akiyama,Yasuto
AU  - Oshita,Chie
AU  - Kume,Akiko
AU  - Iizuka,Akira
AU  - Miyata,Haruo
AU  - Komiyama,Masaru
AU  - Ashizawa,Tadashi
AU  - Yagoto,Mika
AU  - Abe,Yoshiaki
AU  - Mitsuya,Koichi
AU  - Watanabe,Reiko
AU  - Sugino,Takashi
AU  - Yamaguchi,Ken
AU  - Nakasu,Yoko
TI  - α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
SN  - 1471-2407
PY  - 2013///0722
KW  - Adult
KW  - Aged
KW  - Antigens, Neoplasm
KW  - immunology
KW  - Brain Neoplasms
KW  - therapy
KW  - Cancer Vaccines
KW  - Dendritic Cells
KW  - Female
KW  - Glioma
KW  - HLA-A2 Antigen
KW  - genetics
KW  - HLA-A24 Antigen
KW  - Humans
KW  - Immunotherapy, Active
KW  - methods
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1471-2407-12-623
ER  -